Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):1-10. doi: 10.1002/ajmg.b.31137. Epub 2010 Nov 12.
The findings of a recent study associate LPHN3, a member of the latrophilin family, with an increased risk of developing attention deficit/hyperactivity disorder (ADHD), the most common psychiatric disorder in childhood and adolescence. Latrophilins comprise a new family of G protein-coupled receptors of unknown native physiological function that mediate the neurotoxic effects of α-latrotoxin, a potent toxin found in black widow spider venom. This receptor-toxin interaction has helped to elucidate the mechanistic aspects of neurotransmitter and hormone release in vertebrates. Such unprecedented discovery points to a new direction in the assessment of ADHD and suggest that further study of this receptor family may provide novel insights into the etiology and treatment of ADHD and other related psychiatric conditions.
最近的一项研究发现,latrophilin 家族的成员 LPHN3 与注意力缺陷多动障碍(ADHD)的发病风险增加有关,ADHD 是儿童和青少年中最常见的精神疾病。Latrophilins 是一个新的 G 蛋白偶联受体家族,其天然生理功能未知,介导α- latrotoxin 的神经毒性作用,α- latrotoxin 是黑寡妇蜘蛛毒液中的一种强效毒素。这种受体-毒素相互作用有助于阐明脊椎动物中神经递质和激素释放的机制方面。这一前所未有的发现为 ADHD 的评估指明了一个新的方向,并表明对该受体家族的进一步研究可能为 ADHD 及其他相关精神疾病的病因和治疗提供新的见解。